Luke Rajah
Board Member
Luke is a Partner on BGF’s Early Stage team, with a focus on life sciences and deep tech. Prior to BGF, Luke spent three years heading up operations and strategy at Wren Therapeutics, a drug discovery company focused on neurodegenerative diseases. Before that, he was an early-stage investor at Ombu Group in London.
Luke started his career at the Boston Consulting Group, working across the life sciences and industrial sectors. He has a BA and MSci in Natural Sciences and a PhD in Chemistry from the University of Cambridge.
